Literature DB >> 11374811

Localization of immunocompetent cells in the human epididymis.

M Marchlewicz1.   

Abstract

Ultrastructural and immunohistochemical (anti-CD3, CD20, CD45RO, CD68 antibodies) studies of human epididymis were performed. In electron microscopy, lymphocytes and macrophages were observed between epididymal epithelial cells and in the inerstitial tissue. However, immunohistochemical reactions with anti-CD3, CD45RO and CD68 antibodies were positive mainly in cells located the interstitial tissue. The reaction with anti-CD20 antibody was positive neither in epithelium, nor in the interstitial tissue.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11374811

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN： 0239-8508            Impact factor:   1.698


  5 in total

Review 1.  Morphological and histochemical changes in the dromedary camel epididymis in relation to reproductive activity.

Authors:  Zarroug Hassan Ibrahim; Khalid Ali Al-Kheraije; Shio Kumar Singh
Journal:  Histol Histopathol       Date:  2021-01-11       Impact factor: 2.303

2.  Histological and immunohistochemical studies on the epididymal duct in the dromedary camel (Camelus dromedarius).

Authors:  Mohamed Alkafafy; Reda Rashed; Saad Emara; Mohamed Nada; Amr Helal
Journal:  Anat Cell Biol       Date:  2011-12-30

3.  Male accessory gland inflammation prevalence in type 2 diabetic patients with symptoms possibly reflecting autonomic neuropathy.

Authors:  Rosita A Condorelli; Enzo Vicari; Aldo E Calogero; Sandro La Vignera
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

4.  Covid-19 and impairment of spermatogenesis: What if fever was the only cause?

Authors:  M Bendayan; F Boitrelle
Journal:  EClinicalMedicine       Date:  2020-11-29

Review 5.  COVID-19 Infections in Gonads: Consequences on Fertility?

Authors:  Nicole Bechmann; Umberto Maccio; Reham Kotb; Rania Al Dweik; Michele Cherfane; Holger Moch; Stefan R Bornstein; Zsuzsanna Varga
Journal:  Horm Metab Res       Date:  2022-07-19       Impact factor: 2.788
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.